Diehl S R, Boehnke M, Erickson R P, Baxter A B, Bruce M A, Lieberman J L, Platt D J, Ploughman L M, Seiler K A, Sweet A M
Department of Human Genetics, University of Michigan, Ann Arbor 48109.
Genomics. 1987 Dec;1(4):361-3. doi: 10.1016/0888-7543(87)90039-5.
Several recent studies indicate that the von Recklinghausen neurofibromatosis (NF1) gene is located near the centromere of chromosome 17 in some families. However, variable expressivity and a very high mutation rate suggest that defects at several different loci could result in phenotypes categorized as NF1. In order to assess this possibility and to map the NF1 gene more precisely, we have used two polymorphic DNA markers from chromosome 17 to screen several pedigrees for linkage to NF1. We ascertained a large Caucasian pedigree (33 individuals sampled, 17 NF1 affected) as well as eight smaller pedigrees and nuclear families (50 individuals sampled, 30 NF1 affected). Here, we report strong evidence of linkage of NF1 to the centromeric marker D17Z1 (maximum lod = 4.42) and a weaker suggestion of linkage to the ERBA1 oncogene (maximum lod = 0.57), both at a recombination fraction of zero. Since obligate cross-overs with NF1 were not observed for either marker in any of the informative families tested, the possibility of NF1 locus heterogeneity is not supported.
最近的几项研究表明,在一些家族中,冯·雷克林霍增氏神经纤维瘤病(NF1)基因位于17号染色体着丝粒附近。然而,可变表达性和极高的突变率表明,几个不同位点的缺陷可能导致被归类为NF1的表型。为了评估这种可能性并更精确地定位NF1基因,我们使用了来自17号染色体的两个多态性DNA标记,对几个家系进行连锁分析以确定与NF1的关系。我们确定了一个大型白人家系(采样33人,17人患NF1)以及八个较小的家系和核心家庭(采样50人,30人患NF1)。在此,我们报告了NF1与着丝粒标记D17Z1连锁的有力证据(最大对数优势 = 4.42),以及与ERBA1癌基因连锁的较弱证据(最大对数优势 = 0.57),两者的重组率均为零。由于在任何一个被检测的信息丰富的家系中,这两个标记均未观察到与NF1的必然交叉,因此不支持NF1位点异质性的可能性。